Integer Holdings Corp., Plano, Texas, announces that it has purchased certain assets of US BioDesign, a manufacturer of complex braided biomedical structures for disposable and implantable medical devices headquartered in Quakertown, Pa. The acquisition will add differentiated capability for complex braided and formed biomedical structures to Integer’s broad portfolio, further positioning Integer as a partner of choice for innovative medical technologies.
Founded in 2011, US BioDesign serves the cardiovascular, neurovascular, and general surgery markets with nitinol, stainless steel, polymer, and other braided structures that are enabling the next generation of structural heart, peripheral vascular, neurovascular, and electrophysiology products. They also provide product development, material testing, and post-processing services, including electropolishing and packaging.
Integer intends to grow the Quakertown site as a research and development hub, including moving forward with an already planned expansion. Tom Molz, currently President and CEO of US BioDesign, will continue to cultivate the complex braiding business while reporting to Payman Khales, president of Integer’s cardio and vascular business.
Terms of the agreement include an upfront payment of $15 million and potential contingent payments in the future. The impact on sales and adjusted EPS for the current year is expected to be de minimis.
